|
|
|
Insider
Information: |
Diaz Paul J |
Relationship: |
President and CEO, Dir... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,245,906 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$29,210,106 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
1,245,906 |
|
|
Total
Value |
$29,210,106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
36.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Kindred Healthcare Inc |
KND |
Director |
2018-07-02 |
0 |
2003-07-22 |
0 |
Premium* |
|
PharMerica Corporation |
PMC |
Director |
2007-07-31 |
163,671 |
2007-07-31 |
0 |
Premium* |
|
Davita Healthcare Partners |
DVA |
Director |
2023-05-15 |
16,069 |
2007-09-30 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
President and CEO, Dir... |
2024-05-15 |
1,066,166 |
2020-08-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
268 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 11
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DVA |
Davita Healthcare Partner... |
Director |
|
2020-11-30 |
4 |
OE |
$66.17 |
$1,329,923 |
D/D |
19,358 |
18,877 |
0 |
- |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2020-11-30 |
4 |
D |
$109.88 |
$1,330,097 |
D/D |
(12,105) |
14,554 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2024-05-13 |
4 |
S |
$25.13 |
$1,453,550 |
D/D |
(57,844) |
1,236,166 |
0 |
% |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2015-03-20 |
4 |
OE |
$65.08 |
$1,561,920 |
D/D |
24,000 |
28,408 |
0 |
- |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2015-03-20 |
4 |
D |
$81.44 |
$1,561,938 |
D/D |
(19,179) |
9,229 |
0 |
- |
|
KND |
Kindred Healthcare Inc |
President and CEO |
|
2005-06-09 |
4 |
S |
$39.97 |
$1,619,334 |
D/D |
(40,456) |
313,121 |
|
- |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2011-05-19 |
4 |
S |
$86.64 |
$1,663,585 |
D/D |
(19,192) |
866 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2021-09-23 |
4 |
D |
$34.76 |
$1,716,796 |
D/D |
(49,390) |
796,098 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2024-05-15 |
4 |
S |
$25.07 |
$1,880,415 |
D/D |
(75,000) |
1,066,166 |
0 |
% |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2021-08-13 |
4 |
D |
$32.79 |
$1,928,708 |
D/D |
(58,820) |
400,049 |
0 |
- |
|
KND |
Kindred Healthcare Inc |
Director |
|
2015-03-31 |
4 |
D |
$23.79 |
$1,988,725 |
D/D |
(83,595) |
405,610 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2022-08-13 |
4 |
D |
$27.61 |
$1,997,584 |
D/D |
(72,350) |
1,087,079 |
0 |
- |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2014-02-20 |
4 |
OE |
$41.47 |
$2,014,320 |
D/D |
48,000 |
27,101 |
0 |
- |
|
DVA |
Davita Healthcare Partner... |
Director |
|
2014-02-20 |
4 |
D |
$66.07 |
$2,014,408 |
D/D |
(30,489) |
11,675 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
President and CEO |
|
2024-05-14 |
4 |
S |
$25.21 |
$2,394,798 |
D/D |
(95,000) |
1,141,166 |
0 |
% |
|
KND |
Kindred Healthcare Inc |
CEO |
|
2014-03-06 |
4 |
OE |
$15.06 |
$2,496,232 |
D/D |
148,226 |
579,163 |
0 |
- |
|
KND |
Kindred Healthcare Inc |
CEO |
|
2014-03-06 |
4 |
S |
$22.06 |
$2,515,068 |
D/D |
(114,000) |
448,533 |
0 |
- |
|
KND |
Kindred Healthcare Inc |
Director |
|
2018-07-02 |
4 |
D |
$9.00 |
$3,819,060 |
D/D |
(424,340) |
0 |
0 |
- |
|
268 Records found
|
|
Page 11 of 11 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|